Dr. Fangjian Zhou
Claim this profileSun Yat-Sen University Cancer Centre
Studies Prostate Cancer
Studies Tumors
4 reported clinical trials
9 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Tumors
Stage IV
Stage III
Clinical Trials Fangjian Zhou is currently running
Fuzuloparib + AA-P
for Prostate Cancer
This trial is testing whether a combination of Fuzuloparib and AA-P is better for treating advanced prostate cancer. The treatment aims to kill cancer cells by preventing them from fixing their damaged DNA and by reducing hormone levels that help the cancer grow. The study includes patients with and without specific DNA repair deficiencies.
Recruiting1 award Phase 37 criteria
SKB264 + Pembrolizumab
for Solid Tumors
The purpose of this study is to evaluate the efficacy and safety of combination of SKB264 and Pembrolizumab in patients with selected solid tumors including cervical cancer, urothelial cancer, ovarian cancer, prostate cancer.
Recruiting1 award Phase 24 criteria
More about Fangjian Zhou
Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Fangjian Zhou has experience with
- Prednisone
- Abemaciclib
- Fuzuloparib
- Abiraterone Acetate
- Fuzuloparib Placebo
- Abiraterone
Breakdown of trials Fangjian Zhou has run
Prostate Cancer
Cytochrome P450
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fangjian Zhou specialize in?
Fangjian Zhou focuses on Prostate Cancer and Tumors. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Fangjian Zhou currently recruiting for clinical trials?
Yes, Fangjian Zhou is currently recruiting for 2 clinical trials in Guangzhou Guangdong. If you're interested in participating, you should apply.
Are there any treatments that Fangjian Zhou has studied deeply?
Yes, Fangjian Zhou has studied treatments such as Prednisone, Abemaciclib, Fuzuloparib.
What is the best way to schedule an appointment with Fangjian Zhou?
Apply for one of the trials that Fangjian Zhou is conducting.
What is the office address of Fangjian Zhou?
The office of Fangjian Zhou is located at: Sun Yat-Sen University Cancer Centre, Guangzhou, Guangdong 510060 China. This is the address for their practice at the Sun Yat-Sen University Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.